JENNIFER ABALOS: Open Payments
NPI 1841452984 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 67 payments from 17 companies in 2025. Trend: 2023 $396 · 2024 $736 · 2025 $1,533
Food & beverage: $1,464Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $344 |
| Amgen Inc. | 12 | $310 |
| Novo Nordisk Inc | 4 | $176 |
| Dexcom, Inc. | 3 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $122 |
| Astellas Pharma US Inc | 2 | $89 |
| PFIZER INC. | 4 | $78 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| SpectraWAVE, Inc | 2 | $37 |
| Abbott Laboratories | 2 | $36 |
Products named: EVENITY, Ozempic, VRAYLAR, Dexcom G6 Transmitter, CAPLYTA, UBRELVY, QULIPTA, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
